RPG Life Sciences Ltd
Darbepoetin alfa (60mcg)
Darba 60mcg Injection is used in the treatment of anemia that may have occurred due to chronic kidney disease or chemotherapy.
Injection
Darba 60mcg Injection is a medicine that needs to be used with utmost care because it can lead to serious side effects. It is important that you seek treatment from a doctor who is experienced in providing this medical therapy. You should follow all the directions of the doctor strictly. It is given under the supervision of a healthcare professional.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Darba 60mcg Injection is an erythropoiesis-stimulating agent (ESA). It works by stimulating the bone marrow to produce more red blood cells.
Darba 60mcg Injection helps in the treatment of anemia that may have occurred due to chronic kidney disease or cancer chemotherapy. It is given as a single injection under your skin It can be given intravenously. Your doctor may get your blood tests done regularly to monitor the levels of hemoglobin in your blood. Stop taking Darba 60mcg Injection and inform your doctor if you develop shortness of breath or skin rash.
You will begin to notice an increase in your red blood cell count (hemoglobin levels) within 2-6 weeks of starting Darba 60mcg Injection. Consult with your doctor if you have any concerns regarding this process.
Darba 60mcg Injection is a medication that should only be used under the strict guidance of a medical professional. It can lead to serious side effects and even death if not used appropriately. Seek treatment from an experienced healthcare provider familiar with Darba 60mcg Injection therapy. Follow all instructions provided carefully.
You may not respond to Darba 60mcg Injection if you have iron, folic acid, or vitamin B12 deficiencies. Addressing these deficiencies is essential for treatment effectiveness. Other possible reasons for non-response include bleeding, infections, inflammation, bone marrow fibrosis. Consult your healthcare provider for further clarification on this issue.
Darba 60mcg Injection is approved for the treatment of anemia caused by chronic kidney disease in children aged 1 year or older. Its use and potential side effects in children are similar to adults. Consult your doctor if you have any questions about using Darba 60mcg Injection in children.
Darba 60mcg Injection may impact blood pressure, which needs to be monitored during initial therapy. Patients with pre-existing high blood pressure should take necessary steps for blood pressure control. Your doctor might temporarily stop Darba 60mcg Injection if blood pressure remains uncontrolled.
Individuals with active cancer who have not received a doctor-approved prescription for Darba 60mcg Injection should not use it. Additionally, patients with uncontrolled high blood pressure, those with PRCA (pure red cell aplasia) that begins after treatment with Darba 60mcg Injection or other erythropoietin medications, and those with a history of severe allergic reaction to this medication are advised to avoid taking Darba 60mcg Injection.